Table 2.
Characteristics | Stage I-II | Stage III-IV | |||||||
---|---|---|---|---|---|---|---|---|---|
N | Mean OS (months) | X 2 | P value | N | Mean OS (months) | X 2 | P value | ||
NLR | Low | 94 | 54.2 | 10.7 | 0.001 | 82 | 43.9 | 4.9 | 0.027 |
High | 69 | 41.4 | 85 | 34 | |||||
| |||||||||
PLR | Low | 80 | 54.1 | 7.4 | 0.007 | 68 | 42.9 | 2.2 | 0.139 |
High | 83 | 44.9 | 99 | 35.5 | |||||
| |||||||||
CEA (ng/mL) | Low | 140 | 49.8 | 0.7 | 0.383 | 104 | 44.9 | 12.4 | <0.001 |
High | 23 | 43.9 | 63 | 29.5 | |||||
| |||||||||
CEA + NLR | Low | 83 | 54.4 | 8.6 | 0.003 | 58 | 49.6 | 12.1 | 0.001 |
High | 80 | 42.9 | 109 | 33.2 | |||||
| |||||||||
CEA + PLR | Low | 71 | 53.7 | 5.2 | 0.023 | 46 | 47.4 | 5.6 | 0.018 |
High | 92 | 45.9 | 121 | 35.4 | |||||
| |||||||||
NLR + PLR | Low | 64 | 56.2 | 9.9 | 0.002 | 52 | 46.2 | 4.9 | 0.027 |
High | 99 | 44.7 | 115 | 35.3 | |||||
| |||||||||
CEA + NLR + PLR | Low | 58 | 55.6 | 7.2 | 0.007 | 36 | 52.4 | 9.5 | 0.002 |
High | 105 | 45.6 | 131 | 35 |